Article Text

Download PDFPDF
Invasive lobular carcinoma and cytokeratin immunohistochemistry: an audit
  1. I P Chandler,
  2. R Oommen,
  3. C W Lawson
  1. Department of Cellular Pathology, William Harvey Hospital, Ashford, Kent TN24 0LY, UK;

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Small axillary lymph node metastases from an invasive lobular carcinoma of the breast can be notoriously difficult to detect on routine haematoxylin and eosin (H&E) staining. Since August 2001, it has been our departmental policy to carry out immunohistochemistry using a broad spectrum antikeratin antibody (AE1/AE3; Dako Ltd, Ely, Cambridgeshire, UK) to ensure that micrometastases are not missed.

    Between August 2001 and September 2002, 62 patients were coded as having invasive lobular cancer on our database. Twenty …

    View Full Text